Hemitruncus arteriosus, anomalous origin of a pulmonary artery from the aorta, is a rare congenital heart disease frequently accompanied by other cardiovascular anomalies. In this case report, we present an exceedingly rare case of hemitruncus arteriosus in an 18-year-old male patient presenting with cyanosis and chest pain. Echocardiography raised a suspicion for aorto-pulmonary window; this was confirmed on cardiac computed tomography angiography. A magnetic resonance imaging study was performed for functional assessment. The resulting diagnosis was hemitruncus arteriosus with aberrant origin of the right coronary artery from the right pulmonary artery and unilateral absence of a pulmonary artery.

The coronary sinus (CS) normally drains into the right atrium (RA). We report a rare case of anomalous CS drainage into the left atrium (LA). A middle-aged lady underwent coronary computed tomography angiography (CCTA) for evaluation of dyspnea. An earlier transthoracic echocardiogram showed normal chamber sizes and function. The CCTA revealed severe left anterior artery stenosis as well as an anomalous drainage of a normal sized CS into the LA. A small fistula from the CS also communicated with RA. These findings were confirmed during invasive angiography. No further intervention was offered as this was unlikely to be of hemodynamic significance. Nevertheless, understanding of this unusual anatomy will be of importance when planning for electrophysiological or pacing procedures.

The Asian Society of Cardiovascular Imaging-Practical Tutorial (ASCI-PT) is an instructional initiative of the ASCI School designed to enhance educational standards. In 2021, the ASCI-PT was convened with the goal of formulating a consensus statement on the assessment of coronary stenosis and coronary plaque using coronary CT angiography (CCTA). Nineteen experts from four countries conducted thorough reviews of current guidelines and deliberated on eight key issues to refine the process and improve the clarity of reporting CCTA findings. The experts engaged in both online and on-site sessions to establish a unified agreement. This document presents a summary of the ASCI-PT 2021 deliberations and offers a comprehensive consensus statement on the evaluation of coronary stenosis and coronary plaque in CCTA.

Objective: A nitrate-augmented 99mTc-sestamibi cardiac single-photon emission computed tomography imaging protocol has been shown to improve detection of viable cardiac segments. This protocol usually makes use of a short-acting nitrate and requires patients to stop prescribed long-acting nitrate medication for at least two days prior to the study. No previous studies have used long-acting nitrate in myocardial viability research. Materials and Methods: Ten adult patients who had routinely used long-acting nitrate medication participated in this nitrate-augmented myocardial viability study. A long-acting nitrate was given one hour prior to 99mTc-sestamibi injection, and results were evaluated based on uptake changes after nitrate augmentation. Myocardial reversibility was assessed using visual scoring with a 17-segment model, with increased uptake ≥10% considered viable. Results: Eight of 10 patients had a greater than 10% increase in uptake compared to baseline, and nine of 10 patients showed significant changes in sum rest score (SRS) and sum rest nitrate score (SRNS) p<0.001. In most patients, blood pressure dropped significantly after nitrate administration. One patient with no uptake changes or myocardial reversibility based on SRS and SRNS demonstrated increased blood pressure after nitrate administration. Conclusion Oral long-acting nitrates are a feasible option for nitrate-augmented myocardial viability studies. Patients on long-acting nitrate therapy who require myocardial viability study do not need to discontinue the medication prior to the study. Further evaluations with larger samples are needed to confirm these findings.

Objective: Uncorrected atrial septal defect (ASD) leads to pulmonary vascular disease (PVD) later in adulthood. Attempts to close the defect have proven to be detrimental in the presence of PVD. Although right heart catheterization (RHC) is the gold standard for PVD, it remains an invasive approach with complications. Notch characteristics on the right ventricular outflow tract (RVOT) Doppler correlate well with parameters of pulmonary hypertension. Therefore, this study evaluated whether time-to-notch RVOT Doppler could detect PVD in adults with ASD. Materials and Methods: Between March 2019 and June 2020, we consecutively sampled adult patients with ostium secundum ASD. Time-to-notch was examined by transthoracic echocardiogram within 24 hours of RHC. A vasoreactivity test was performed when the ratio of resistance arterial pulmonary to systemic (PVR:SVR) was ≥0.33. PVD was diagnosed if the final resistance ratio was ≥0.33. Results: We analysed 89 subjects with ASD. A vasoreactivity test was performed in 54 patients with pure oxygen, and 37% (n=24) had PVD. The majority of subjects in this study were women (85%) with a median age of 38 years. The time-to-notch RVOT Doppler was significantly shorter in subjects with PVD compared to those without (132±17 ms vs. 177±29 ms, p<0.001). The area under the curve was 0.923 for time-to-notch to predict PVR:SVR ≥0.33. A cutoff point of <147.5 ms was able to detect PVD (sensitivity 88%, specificity 87%, positive predictive value 72%, negative predictive value 95%, positive likelihood ratio [LR] 7.11, and negative LR 0.14). Conclusion Time-to-notch RVOT Doppler has substantial predictive value in detecting PVD in secundum ASD-pulmonary arterial hypertension populations.

Danon disease is a rare genetic cardio-skeletal myopathy. We present a case of an 18-year-old patient experiencing intermittent chest pain, dyspnea, and palpitations. Initial investigations unveiled elevated NT-pro brain natriuretic peptide, creatinine kinase, and cardiac enzyme levels.Electrocardiogram findings displayed left ventricular hypertrophy with a strain pattern and left bundle branch block. Transthoracic echocardiography and cardiac magnetic resonance imaging confirmed severe concentric left ventricular hypertrophy, accompanied by late gadolinium enhancement in specific myocardial regions. Genetic testing identified prevalent frameshift mutations in the lysosomal-associated membrane protein-2 (LAMP2) gene, indicative of Danon disease. This condition manifests as a severe, early-onset cardiomyopathy with associated complications such as heart failure, arrhythmias, and conduction disturbances, particularly in males. Diagnosis relies on genetic evidence, emphasizing the significance of testing in conjunction with clinical and imaging tools.

In vasospastic angina, exercise typically does not lead to vasoconstriction. We present the case of a patient with an atypical presentation of vasospastic angina, characterized by regional wall motion abnormalities confirmed by exercise stress echocardiography. A 58-yearold female patient presented to the hospital reporting chest pain during both exercise. During the exercise stress echocardiogram, regional wall motion abnormality was confirmed.However, the coronary angiography did not reveal significant lesions. Subsequently, ergonovine test was positive and then exercise induced vasospastic angina was diagnosed. Following medical treatment, the patient’s symptoms showed improvement. This case underscores an uncommon presentation of vasospastic angina in an individual already diagnosed with coronary artery disease, indicating that exercise stress echocardiography could serve as a valuable screening tool for specific types of vasospastic angina.

Objective: Optical coherence tomography (OCT) is considered superior to coronary angiography (CA). However, OCT is not widely used, and data are limited in India. In the present study, the efficacy and safety of OCT for guiding percutaneous coronary intervention (PCI) in all-comer patients were evaluated and compared with those of CA. Materials and Methods: In this retrospective study, the data associated with 434 patients who underwent PCI between December 2018 and June 2020 were analyzed. The primary endpoint was major adverse cardiac events (MACEs) at 6 months. Results: The patients were divided into OCT-guided and angiography-guided PCI groups (217 in each group) after propensity matching. The OCT-guided PCI group had a significantly larger proportion of patients with unstable angina (55.7% vs. 43.3%, p=0.009) and non-STelevation myocardial infarction (NSTEMI; 17.5% vs. 10.0%, p=0.02) compared with the angiography-guided PCI group, and the proportion of patients with STEMI was significantly lower in the OCT-guided PCI group than in the angiography-guided PCI group (23.5% vs. 41.5%, p=0.00005). The OCT-guided PCI group had a lower incidence of MACEs at 6 months than the angiography-guided PCI group but without statistical significance (6.9% vs. 9.7%, p=0.296).Incidences of target lesion failure, target vessel myocardial infarction, in-stent restenosis, or stent thrombosis did not occur in either group. On post-PCI OCT, stent underexpansion, tissue prolapse, stent edge dissection, and stent malapposition were observed in 28.5%, 10%, 4.1%, and 3.7% of the cases, respectively. Conclusion When comparing OCT-guided PCI with angiography-guided PCI, OCT-guided PCI showed slightly superior clinical outcomes at 6 months, although the differences were not statistically significant.

A 43-year-old male with no past medical history presented with acute onset palpitations, chest pain and diaphoresis. Electrocardiogram showed atrial fibrillation with rapid ventricular response. High-sensitivity cardiac troponin I was elevated at 87 ng/L at presentation and rose further to 1874 ng/L 8 hours later. Invasive coronary angiography revealed significant stenosis of the left circumflex artery, which was treated with percutaneous coronary intervention. Transthoracic echocardiography showed severe left ventricular hypertrophy with mild systolic anterior motion of the anterior mitral leaflet. Cardiac magnetic resonance demonstrated features consistent with hypertrophic cardiomyopathy with regional fibrosis. Of note, focal delayed enhancement was seen in the anterolateral papillary muscle.